Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04635345
Other study ID # 278027
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 11, 2021
Est. completion date August 2024

Study information

Verified date August 2023
Source Barts & The London NHS Trust
Contact Jessica Gaddie, MbCHb, BSc
Phone 0207 377 7315
Email j.gaddie1@nhs.net
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The acceptability of vulvar vibration therapy has been evaluated in women with vulvodynia, and found to be acceptable, however has not been assessed in women with a primary complaint of vaginismus. This proposed study looks at the feasibility and acceptability of using clitoral vibration therapy, alongside current therapy, for women with vaginismus. It is likely that many, if not most, of these women will also have an element of vulvodynia. The investigators propose that the use of external clitoral or vulval vibration therapy is likely to be acceptable in most women with vaginismus, based on acceptability of vulvar vibration therapy in women with vulvodynia. It is proposed that vibrator therapy may help women with female sexual dysfunction to use vaginal dilators.


Description:

This is a nonrandomized controlled trial, with the initial cluster of patients receiving standard therapy, and the second cluster receiving standard therapy plus vibrator. Recruitment will be an initial 15 participants who will receive standard therapy, and then another 15 who will receive an external vibrator. This study will take place over approximately 12 months. Enrollment of patients will be from a joint psychosexual clinic led by a medical doctor and a clinical psychologist. Female patients are referred to this clinic by General Practitioners, from within the Sexual Health service, or via Gynaecologists, frequently with complaint of difficulty or pain with penetrative sex. Exclusion criteria will be: patients unable/ unwilling to consent, transgender male or on testosterone therapy, unable to understand written and/or verbal English, current dermtatological skin conditions requiring active treatment, genital herpes simplex virus within 3 months, or not reporting symptoms of vaginismus with no evidence of vaginismus on clinical examination. Trial information will be given at the initial appointment. If the patient wishes to enrol, than an initial baseline questionnaire will be given, and a follow up questionnaire will be filled out by phone contact at 3-4 months afterward the initial consultation at the patients consent.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Able and willing to give informed consent (additional measures have to be in place if children, vulnerable adults or adults unable to give consent are included) - Female - Over the age of 18 - With symptoms and clinical signs consistent with vaginismus/ vaginismus and vulvodynia. Exclusion Criteria: - Unwilling or unable to give consent - Transgender male / on testosterone therapy - Inability to understand written and / or verbal English - Current dermatological skin conditions requiring active treatment - Genital herpes simplex virus symptoms within preceding 3 months - Not reporting symptoms of vaginismus, and no evidence of vaginismus on clinical examination.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
External Vibrator - patient-administered.
Patient provided with external vibrator for self-use, as well as vaginal dilators.
Standard care
Dilators, lidocaine topical gel, referral to psychotherapy, group therapy or womens health physio if required, self-help resources.

Locations

Country Name City State
United Kingdom Ambrose King Sexual Health Centre London

Sponsors (1)

Lead Sponsor Collaborator
Barts & The London NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Is vibration therapy (through the use of handheld external vibrators on clitoral and vulval area) acceptable to women as part of medical management of vaginismus and vaginismus/vulvodynia, alongside current medical management? Qualitative questionnaire 12-18 months
Secondary Does the use of clitoral/ vulval vibrators help women to progress more easily with the use of vaginal dilators compared to women not using these? Qualitative questionnaire 12-24 months
Secondary Is there any self-reported difference in experiences of pleasure or enjoyment around sexual experiences in the two groups of women as reported by FSDS (Female Sexual Distress Scale) Scores? Questionnaire - FSDS (above) 12-24 months
Secondary Is there any self-reported difference in experiences of pleasure or enjoyment around sexual experiences in the two groups of women as reported by FSFI (Female Sexual Function Index) Scores? Questionnaire - FSFI (above) 12-24 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT00638066 - Botulinum Toxin Injection for Treatment of Vaginismus Phase 3
Not yet recruiting NCT01530113 - Childhood Sexual Abuse, Vaginismus and Labor Dystocia N/A
Recruiting NCT05529407 - Trial of SVTampons vs Glass Vaginal Dilators in Treatment of Vaginismus N/A
Completed NCT01859507 - Injection of Botox in the Perineal Muscles in Resistant Cases of Vaginal Spasm N/A
Completed NCT04436172 - Spinal Anesthesia Facilitated Sexual Intercourse As A Treatment Option For Vaginismus N/A
Completed NCT00281372 - Sexual Dysfunction and Dental Care N/A
Completed NCT03176069 - Evaluation and Comparison of Women Pelvic Floor With and Without Sexual Dysfunction (Vaginismus) N/A
Completed NCT01352546 - Botox Injection for Treatment of Vaginismus Phase 1
Recruiting NCT06397885 - Prospective On Market Patient-reported Outcomes for Milli
Completed NCT02430038 - Transperineal Ultrasound to Assess the Progress of Labour